By Guest Blogger Dana Deighton Though my 25 years of professional experiences are mostly rooted in marketing, the last 15 years or so of my personal life have...
Clinical trials are a critical part of the development of new treatments. They rely on people who volunteer to participate and are then closely monitored by...
As our programs at TargetCancer Foundation continue to expand, we remain committed to our primary mission of funding innovative rare cancer research. We are...
Earlier this week, TargetCancer Foundation joined with the National Organization of Rare Disorders (NORD) and 81 other rare advocacy organizations to express...
The following post is written by Kristen Palma Poth, TargetCancer Foundation President Eight. It is a number that carries a meaning for me that I never could...
Citizen Advocacy – DC legislators welcome our passionate voices during Rare Disease Week 2017 by Bill Drake, TargetCancer Foundation Advocacy Council Member...
By TargetCancer Foundation Advocacy Council Member DJ Webster Last Thursday, TargetCancer Foundation traveled to Washington D.C. for the annual in-person...